Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Davidson

Showing results (101-110 of 358) with videos related to

Pageof 36
Sort By:
Virchows Archiv : an International Journal of Pathology|June 14, 2020
Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinomaBen Davidson, Erin McFadden, Arild Holth, et al.
Oncotarget|June 21, 2019
Molecular characterization of carcinosarcomas arising in the uterus and ovariesMarta Brunetti, Antonio Agostini, Julie Staurseth, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 5, 2011
Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspectiveMari B Elstrand, Berit Sandstad, Halldis Oksefjell, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2012
Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?Claes G Tropé, Mari B Elstrand, Berit Sandstad, et al.
Human Pathology|June 1, 2012
Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinomaOlga Vaksman, Thea Eline Hetland, Claes G Trope', et al.
Oncotarget|May 4, 2018
Identification of an <i>EPC2-PHF1</i> fusion transcript in low-grade endometrial stromal sarcomaMarta Brunetti, Ludmila Gorunova, Ben Davidson, et al.
Seminars in Diagnostic Pathology|October 19, 2006
The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesotheliomaBen Davidson, Björn Risberg, Aasmund Berner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2018
Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy OnlyElisabeth Smogeli, Milada Cvancarova, Yun Wang, et al.
Oncology Letters|August 13, 2020
Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancerMarta Brunetti, Ioannis Panagopoulos, Ilyá Kostolomov, et al.
Breast (Edinburgh, Scotland)|November 17, 2010
CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survivalBen Davidson, Helene Tuft Stavnes, Mette Førsund, et al.
Pageof 36

Showing results (101-110 of 358) with videos related to

Sort By:
Pageof 36
Virchows Archiv : an International Journal of Pathology|June 14, 2020
Death domain-associated protein (DAXX) expression is associated with poor survival in metastatic high-grade serous carcinomaBen Davidson, Erin McFadden, Arild Holth, et al.
Oncotarget|June 21, 2019
Molecular characterization of carcinosarcomas arising in the uterus and ovariesMarta Brunetti, Antonio Agostini, Julie Staurseth, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 5, 2011
Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspectiveMari B Elstrand, Berit Sandstad, Halldis Oksefjell, et al.
European Journal of Cancer (Oxford, England : 1990)|March 3, 2012
Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV?Claes G Tropé, Mari B Elstrand, Berit Sandstad, et al.
Human Pathology|June 1, 2012
Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinomaOlga Vaksman, Thea Eline Hetland, Claes G Trope', et al.
Oncotarget|May 4, 2018
Identification of an <i>EPC2-PHF1</i> fusion transcript in low-grade endometrial stromal sarcomaMarta Brunetti, Ludmila Gorunova, Ben Davidson, et al.
Seminars in Diagnostic Pathology|October 19, 2006
The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesotheliomaBen Davidson, Björn Risberg, Aasmund Berner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 27, 2018
Clinical Outcome of Patients With High-Risk Endometrial Carcinoma After Treatment With Chemotherapy OnlyElisabeth Smogeli, Milada Cvancarova, Yun Wang, et al.
Oncology Letters|August 13, 2020
Mutation analysis and genomic imbalances of cells found in effusion fluids from patients with ovarian cancerMarta Brunetti, Ioannis Panagopoulos, Ilyá Kostolomov, et al.
Breast (Edinburgh, Scotland)|November 17, 2010
CD105 (Endoglin) expression in breast carcinoma effusions is a marker of poor survivalBen Davidson, Helene Tuft Stavnes, Mette Førsund, et al.
Pageof 36